Esra Bağlan

487 total citations
43 papers, 181 citations indexed

About

Esra Bağlan is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Esra Bağlan has authored 43 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Surgery. Recurrent topics in Esra Bağlan's work include Inflammasome and immune disorders (19 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Kawasaki Disease and Coronary Complications (9 papers). Esra Bağlan is often cited by papers focused on Inflammasome and immune disorders (19 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Kawasaki Disease and Coronary Complications (9 papers). Esra Bağlan collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Esra Bağlan's co-authors include Semanur Özdel, Mehmet Bülbül, Mustafa Çakan, Hafize Emine Sönmez, Betül Sözeri, Kübra Öztürk, Gülçin Otar Yener, Nuray Aktay Ayaz, Ferhat Demir and Şerife Gül Karadağ and has published in prestigious journals such as Journal of Clinical Medicine, Pediatric Nephrology and European Journal of Pediatrics.

In The Last Decade

Esra Bağlan

36 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Bağlan Türkiye 7 92 60 53 47 44 43 181
G. K. Yardimci Türkiye 8 119 1.3× 93 1.6× 36 0.7× 92 2.0× 37 0.8× 48 204
Nazife Şule Yaşar Bilge Türkiye 11 168 1.8× 94 1.6× 39 0.7× 67 1.4× 39 0.9× 38 284
Alyette Duquesne France 7 135 1.5× 66 1.1× 45 0.8× 29 0.6× 74 1.7× 7 244
Seher Şener Türkiye 8 42 0.5× 21 0.3× 43 0.8× 67 1.4× 39 0.9× 48 167
Ayako Tsuchiya‐Suzuki Japan 9 284 3.1× 159 2.6× 78 1.5× 31 0.7× 33 0.8× 12 306
Luciana Martins de Carvalho Brazil 8 41 0.4× 114 1.9× 17 0.3× 132 2.8× 50 1.1× 23 225
Adeline Lacraz France 3 33 0.4× 25 0.4× 42 0.8× 70 1.5× 43 1.0× 3 196
Fulya Coşan Türkiye 11 124 1.3× 117 1.9× 20 0.4× 100 2.1× 60 1.4× 30 296
Virginia Messia Italy 8 53 0.6× 52 0.9× 77 1.5× 66 1.4× 63 1.4× 24 185
Iman I. El‐Gazzar Egypt 9 37 0.4× 90 1.5× 16 0.3× 109 2.3× 52 1.2× 17 214

Countries citing papers authored by Esra Bağlan

Since Specialization
Citations

This map shows the geographic impact of Esra Bağlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Bağlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Bağlan more than expected).

Fields of papers citing papers by Esra Bağlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Bağlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Bağlan. The network helps show where Esra Bağlan may publish in the future.

Co-authorship network of co-authors of Esra Bağlan

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Bağlan. A scholar is included among the top collaborators of Esra Bağlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Bağlan. Esra Bağlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Çakan, Mustafa, Özlem Akgün, Gülçin Otar Yener, et al.. (2024). The journey of MEFV heterozygous children: with or without colchicine. European Journal of Pediatrics. 184(1). 40–40. 1 indexed citations
3.
Bağlan, Esra, Deniz Gezgin Yıldırım, Mustafa Çakan, et al.. (2024). Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study. The Turkish Journal of Pediatrics. 66(1). 81–89. 2 indexed citations
4.
İşgüder, Rana, Şerife Gül Karadağ, Esra Bağlan, et al.. (2023). Clinical characteristics and predictors for recurrence in chronic nonbacterial osteomyelitis: a retrospective multicenter analysis. TURKISH JOURNAL OF MEDICAL SCIENCES. 53(5). 1105–1111. 2 indexed citations
5.
Çoşkuner, Taner, Esra Bağlan, Gülçin Otar Yener, et al.. (2023). Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG). Clinical Rheumatology. 43(1). 407–413. 1 indexed citations
6.
Özdel, Semanur, et al.. (2023). Changing face of non-infectious pediatric uveitis in the pre-pandemic and pandemic periods: a comparison study. Postgraduate Medicine. 135(4). 418–423. 1 indexed citations
7.
Ceylaner, Serdar, et al.. (2023). A novel mutation in the proteoglycan 4 gene causing CACP syndrome: two sisters report. Pediatric Rheumatology. 21(1). 8–8. 5 indexed citations
8.
Bağlan, Esra, Figen Çakmak, Gülçin Otar Yener, et al.. (2023). Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG). Clinical Rheumatology. 42(10). 2855–2860. 2 indexed citations
9.
Bağlan, Esra, et al.. (2023). The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever. Clinical Rheumatology. 43(1). 387–392.
10.
Sönmez, Hafize Emine, Gülçin Otar Yener, Mustafa Çakan, et al.. (2022). The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis. Journal of Clinical Medicine. 11(6). 1742–1742. 6 indexed citations
11.
Güngör, Tülin, et al.. (2022). The importance of ambulatory blood pressure monitoring for diagnosing masked hypertension in patients with renal parenchymal scarring. Pediatric Nephrology. 38(4). 1215–1222. 1 indexed citations
12.
Sönmez, Hafize Emine, Gülçin Otar Yener, Esra Bağlan, et al.. (2022). Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19. Frontiers in Pediatrics. 10. 942455–942455. 13 indexed citations
13.
Özdel, Semanur, et al.. (2022). Clinical spectrum of immunoglobulin A vasculitis in children and determining the best timing of urine examination to predict renal involvement. Postgraduate Medicine. 134(4). 441–447. 1 indexed citations
14.
Sözeri, Betül, Hafize Emine Sönmez, Ferhat Demir, et al.. (2021). Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey. Rheumatology International. 42(1). 87–94. 6 indexed citations
15.
Öztürk, Kübra, Ayşe Tanatar, Esra Bağlan, et al.. (2021). Low disease activity state in juvenile-onset systemic lupus erythematosus. Lupus. 30(13). 2144–2150. 13 indexed citations
16.
Güngör, Tülin, et al.. (2021). Retrospective evaluation of children with unilateral renal agenesis. Pediatric Nephrology. 36(9). 2847–2855.
18.
Özdel, Semanur, et al.. (2020). Two pediatric cases of isotretinoin‐induced sacroiliitis successfully treated with adalimumab. Pediatric Dermatology. 37(5). 929–931. 2 indexed citations
19.
Özdel, Semanur, Gökçe Gür, Fehime Kara Eroğlu, et al.. (2019). MEFV gene mutations in children with Henoch–Schönlein purpura and their correlations—do mutations matter?. Clinical Rheumatology. 38(7). 1947–1952. 14 indexed citations
20.
Özdel, Semanur, et al.. (2019). The Effect of Canakinumab Treatment on the Inflammatory Markers in Children with Colchicine-Resistant Familial Mediterranean Fever. Iranian Journal of Pediatrics. 29(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026